Comments
Loading...

Aprea Therapeutics

APRENASDAQ
Logo brought to you by Benzinga Data
$3.49
-0.04-1.13%
At close: -
$3.33
-0.16-4.58%
After Hours: Feb 12, 9:20 AM EDT

Aprea Therapeutics (NASDAQ:APRE) Stock Quotes, Forecast and News Summary

Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.

Open$3.59
Close$3.49
Volume / Avg.11.44K / 28.47K
Day Range$3.49 - $3.72
52 Wk Range2.15 - 8.85
Market Cap$18.97M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
45
Short Interest
1.11%
Days to Cover1.66
About Aprea Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precis...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
APRE
NKGN

FAQ

Q

How do I buy Aprea Therapeutics (APRE) stock?

A

You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aprea Therapeutics (APRE) competitors?

Q

What is the forecast, or price target, for Aprea Therapeutics (APRE) stock?

A

Aprea Therapeutics has a consensus price target of $10.60.

Q

What is the current price for Aprea Therapeutics (APRE)?

A

The stock price for Aprea Therapeutics (NASDAQ: APRE) is $3.49 last updated February 18, 2025 at 4:00 PM EST.

Q

Does Aprea Therapeutics (APRE) pay a dividend?

A

There are no upcoming dividends for Aprea Therapeutics.

Q

When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?

A

Aprea Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Q

Is Aprea Therapeutics (APRE) going to split?

A

There is no upcoming split for Aprea Therapeutics.

Q

What sector and industry does Aprea Therapeutics (APRE) operate in?

A

Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch